US senators press Allergan for details on patent deal with tribe Ruby Khatun Khatun9 Nov 2017 9:15 AM ISTA group of U.S. senators on Tuesday asked drugmaker Allergan Plc to produce documents relating to its agreement to transfer patents to a Native...
Cipla shares tank over 7 percent, mcap falls by Rs 3,785.5 crore Ruby Khatun Khatun8 Nov 2017 10:21 AM ISTNew Delhi: Shares of Cipla slumped over 7 percent even as the company reported a consolidated net profit of Rs 434.95 crore for the second quarter...
Narayana Hrudayalaya Q2 FY18 Consolidated operating income at Rs 5,592 million Ruby Khatun Khatun8 Nov 2017 10:07 AM ISTBengaluru: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, announced its financial results for the second quarter (Q2...
Novartis seeks European approval for cell therapy Kymriah Ruby Khatun Khatun8 Nov 2017 9:47 AM ISTZURICH: Swiss drugmaker Novartis has submitted its cell therapy Kymriah for European approval in two forms of blood cancer, seeking to expand the use...
Bayer in bid to broaden use of anti-clotting drug Xarelto Ruby Khatun Khatun8 Nov 2017 9:31 AM ISTFRANKFURT: German drugmaker Bayer on Monday moved to tap a potentially lucrative new market opportunity for its blockbuster clot prevention drug...
Valeant to sell female libido pill business back to former owners Ruby Khatun Khatun8 Nov 2017 9:15 AM ISTValeant Pharmaceuticals International Inc said on Monday it will sell its female libido-pill business Sprout Pharmaceuticals back to its former...
FDA approves Roche drugs for rare types of blood, lung cancers Ruby Khatun Khatun7 Nov 2017 10:27 AM ISTRoche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood...
Takeda takes on Sanofi with new global dengue vaccine data Ruby Khatun Khatun7 Nov 2017 10:07 AM ISTTakeda Pharmaceutical's experimental dengue vaccine has produced promising long-term results in clinical tests, boosting the Japanese company's global...
Johnson and Johnson Stelara shows promise against lupus in study Ruby Khatun Khatun7 Nov 2017 9:47 AM ISTJohnson and Johnson’s blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared...
Former GSK boss to lead new UK accelerated drug access scheme Ruby Khatun Khatun7 Nov 2017 9:30 AM ISTLONDON: Former GlaxoSmithKline (GSK) boss Andrew Witty is to lead a new British scheme to accelerate access to ground-breaking medicines for...
Natco's partner Alvogen gets nod for influenza drug in US supriya kashyap kashyap6 Nov 2017 10:30 AM ISTNew Delhi: Natco Pharma said its marketing partner Alvogen has received final approval to market oseltamivir phosphate powder used for the treatment...
Syngene International draws up 102 million dollars spending programme Ruby Khatun Khatun6 Nov 2017 10:02 AM ISTMumbai: Leading contract research and manufacturing organization Syngene International Ltd said it will invest USD 102 million to build new...
